Cargando…
Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease
OBJECTIVES: This study aims to analyze gene expression in lung tissue and lung fibroblasts of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) to identify potential biomarkers and therapeutic targets and to examine its possible role in the pathogenesis of SSc-ILD. PATI...
Autores principales: | Huang, Biqing, Li, Jing, Zhao, Jiuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957772/ https://www.ncbi.nlm.nih.gov/pubmed/35382367 http://dx.doi.org/10.46497/ArchRheumatol.2021.8625 |
Ejemplares similares
-
Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012) -
MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis
por: Li, Yiqun, et al.
Publicado: (2021) -
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019) -
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020) -
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
por: Meier, C., et al.
Publicado: (2020)